British woman receives world-first cancer therapy

&Tab;&Tab;<div class&equals;"wpcnt">&NewLine;&Tab;&Tab;&Tab;<div class&equals;"wpa">&NewLine;&Tab;&Tab;&Tab;&Tab;<span class&equals;"wpa-about">Advertisements<&sol;span>&NewLine;&Tab;&Tab;&Tab;&Tab;<div class&equals;"u top&lowbar;amp">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;<amp-ad width&equals;"300" height&equals;"265"&NewLine;&Tab;&Tab; type&equals;"pubmine"&NewLine;&Tab;&Tab; data-siteid&equals;"111265417"&NewLine;&Tab;&Tab; data-section&equals;"1">&NewLine;&Tab;&Tab;<&sol;amp-ad>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;<&sol;div><p>A British woman has become the first in the world to be treated with a revolutionary new therapy which injects a high dose of chemotherapy into cancer cells&period;<&sol;p>&NewLine;<p>Karen Childs&comma; from north-west London&comma; is taking part in a clinical trial for acoustic cluster therapy to treat cancer that has spread to her liver&period;<&sol;p>&NewLine;<p>During the therapy&comma; clusters of microdroplets and microbubbles are injected into the patient at the same time as chemotherapy&comma; where they work to enhance its delivery&period;<&sol;p>&NewLine;<p>Ultrasound scans are used to ensure the clusters &OpenCurlyDoubleQuote;pump” the drug into the tumour&comma; meaning substantially more chemotherapy reaches cancer cells&period;<&sol;p>&NewLine;<p>Experts hope the technique will mean patients have fewer doses of chemotherapy in the future&comma; reducing the risk of side-effects&period;<&sol;p>&NewLine;<div class&equals;"unruly&lowbar;in&lowbar;article&lowbar;placement" data-unruly-ad-type&equals;"horizontal"><&sol;div>&NewLine;<p>The new treatment is being trialled by the Institute of Cancer Research &lpar;ICR&rpar; in London and the Royal Marsden NHS Foundation Trust&period;<&sol;p>&NewLine;<p>Ms Childs&comma; who was diagnosed with cancer in November 2013&comma; said&colon; <em>&OpenCurlyDoubleQuote;I’m not sure it’s sunk in yet that I’m the very first patient in the world to be receiving this new treatment&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;This trial is an exciting step for the hospital and a huge step for patients like me&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;It really would make a big difference to patients’ lives if side-effects could be reduced in the future using more targeted treatments like this&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;It’s an incredible opportunity to be on this trial and the staff at the Royal Marsden have been amazing and very supportive&period;”<&sol;em><&sol;p>&NewLine;<p>The aim of the clinical trial&comma; which is still in its early stages&comma; is to provide data on the effectiveness of the treatment as well as to establish its safety&period;<&sol;p>&NewLine;<p>The therapy is being used to treat patients with tumours in the liver that have spread from the bowel or pancreas&period;<&sol;p>&NewLine;<p>Eventually&comma; the technique could be used to reduce the size of tumours before surgery – making them removable and potentially offering more patients a cure&period;<&sol;p>&NewLine;<p>The clinical trial is largely funded by Phoenix Solutions&comma; which developed the technique&comma; and the Research Council of Norway&period;<&sol;p>&NewLine;<p>Jeffrey Bamber&comma; professor in physics applied to medicine&comma; who led the work to develop and evaluate the technology at the ICR&comma; said&colon; <em>&OpenCurlyDoubleQuote;We’re delighted that our work on innovative acoustic cluster therapy – which is designed to overcome barriers to drug delivery that tumours develop – has progressed to the point where the technology is now being assessed in patients for the first time&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;It’s a very exciting &OpenCurlyQuote;door-opening’ technology which concentrates more of the drug in the tumour&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;We expect eventually to be able to both treat tumours more effectively and reduce the rate and severity of side effects&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;In the long term&comma; we hope this technology will be of particular benefit in difficult-to-treat tumours&comma; such as those of the pancreas&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;It may also assist new types of treatments such as immunotherapy&period;”<&sol;em><&sol;p>&NewLine;<p>Professor Udai Banerji&comma; deputy director of drug development at the ICR and Royal Marsden NHS Foundation Trust&comma; said&colon; <em>&OpenCurlyDoubleQuote;We’re hopeful we can help open up a much-needed new option for patients with hard-to-treat advanced cancer&period;<&sol;em><&sol;p>&NewLine;<p><em>&OpenCurlyDoubleQuote;This trial is a real cross-team effort involving radiologists&comma; physicists and nurses who all work together to provide the treatment and support the patient throughout the process&period;”<&sol;em><&sol;p>&NewLine;&Tab;&Tab;&Tab;<div style&equals;"padding-bottom&colon;15px&semi;" class&equals;"wordads-tag" data-slot-type&equals;"belowpost">&NewLine;&Tab;&Tab;&Tab;&Tab;<div id&equals;"atatags-dynamic-belowpost-68ecc9a29b3d4">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<script type&equals;"text&sol;javascript">&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback &equals; function &lpar;&rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; false &equals;&equals;&equals; &lpar; window&period;isWatlV1 &quest;&quest; false &rpar; &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&sol;&sol; Use Aditude scripts&period;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings &equals; window&period;tudeMappings &vert;&vert; &lbrack;&rsqb;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;tudeMappings&period;push&lpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;divId&colon; 'atatags-dynamic-belowpost-68ecc9a29b3d4'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;format&colon; 'belowpost'&comma;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;if &lpar; document&period;readyState &equals;&equals;&equals; 'loading' &rpar; &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;document&period;addEventListener&lpar; 'DOMContentLoaded'&comma; window&period;getAdSnippetCallback &rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub; else &lbrace;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;window&period;getAdSnippetCallback&lpar;&rpar;&semi;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;&Tab;&rcub;&NewLine;&Tab;&Tab;&Tab;&Tab;&Tab;<&sol;script>&NewLine;&Tab;&Tab;&Tab;&Tab;<&sol;div>&NewLine;&Tab;&Tab;&Tab;<&sol;div>


Discover more from London Glossy Post

Subscribe to get the latest posts sent to your email.

- Advertisement -
Exit mobile version